SK pharmteco Showcases Global CDMO Manufacturing at CPHI
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy Healthcare Innovation healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurodegenerative Disease Neurology Oncology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
Rancho Cordova, California, USA, August 21, 2026 SK pharmteco, a global contract development and manufacturing organization (CDMO), has announced...
RANCHO CORDOVA, Calif., June 23, 2026 SK pharmteco has introduced SKyvecâ„¢, a next-generation multimodal viral vector platform designed to...
